LABORATORY CORP OF AMERICA HOLDINGS (LH) is a publicly traded company in the Unknown sector. Across all available filings, 36 corporate insiders have executed 1039 transactions totaling $185.2M, demonstrating a bearish sentiment with -$183.1M in net insider flow. The most recent transaction on Feb 24, 2026 involved a sale of 1,500 shares valued at $429.5K.
No significant insider buying has been recorded for LH in the recent period.
No significant insider selling has been recorded for LH in the recent period.
Based on recent SEC filings, insider sentiment for LH is bearish with an Insider Alignment Score of 1/100 and a net flow of -$183.1M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at LABORATORY CORP OF AMERICA HOLDINGS (LH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 36 insiders are actively trading LH stock, having executed 1039 transactions in the past 90 days. The most active insider is David P. King (Executive), who has made 74 transactions totaling $163.7M.
Get notified when executives and directors at LH file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | J. Caveney Brian | EVP, Pres of ED, CMO & CSO | Sale | 1,500 | $286.31 | $429.5K | |
| Feb 19, 2026 | J. Wilkinson Peter | SVP, Chief Accounting Officer | Sale | 666 | $277.94 | $185.1K | |
| Feb 10, 2026 | B. Anderson Kerrii | Executive | Award | 773 | $N/A | $0 | |
| Feb 10, 2026 | Victor Bulto Carulla | Executive | Award | 773 | $N/A | $0 | |
| Feb 10, 2026 | A. Davis Jeffrey | Executive | Award | 773 | $N/A | $0 | |
| Feb 10, 2026 | Marie Kliphouse Kirsten | Executive | Award | 773 | $N/A | $0 | |
| Feb 10, 2026 | M. Neupert Peter | Executive | Award | 773 | $N/A | $0 | |
| Feb 10, 2026 | P. Parham Richelle | Executive | Award | 773 | $N/A | $0 | |
| Feb 10, 2026 | E. Wengel Kathryn | Executive | Award | 773 | $N/A | $0 | |
| Feb 10, 2026 | H. Sampson John | Executive | Award | 773 | $N/A | $0 | |
| Feb 10, 2026 | Rothman Paul | Executive | Award | 733 | $N/A | $0 | |
| Feb 10, 2026 | Kong Garheng | Executive | Award | 773 | $N/A | $0 | |
| Feb 9, 2026 | H. Schechter Adam | Executive | Payment | 1,352 | $274.01 | $370.5K | |
| Feb 9, 2026 | Oyegunwa Akinbolade | EVP, CIO & CTO | Payment | 51 | $274.01 | $14.0K | C-Suite |
| Feb 7, 2026 | H. Schechter Adam | Executive | Option Exercise | 3,249 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 195 | $184.2M | 53.8% |
Payment(F) | 345 | $97.0M | 28.3% |
Exercise(M) | 415 | $60.0M | 17.5% |
Purchase(P) | 7 | $1.0M | 0.3% |
Award(A) | 61 | $0 | 0.0% |
Gift(G) | 16 | $0 | 0.0% |
Insider selling pressure at LABORATORY CORP OF AMERICA HOLDINGS has increased, with 36 insiders executing 1039 transactions across all time. Total sales of $184.2M significantly outpace purchases of $1.0M, resulting in a net outflow of $183.1M. This selling activity appears largely discretionary, which may warrant closer attention from investors.